<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02673775</url>
  </required_header>
  <id_info>
    <org_study_id>Pro20140001089</org_study_id>
    <secondary_id>R01ES004738</secondary_id>
    <nct_id>NCT02673775</nct_id>
  </id_info>
  <brief_title>Air Pollution Study: The Effect of Ozone on the Lung</brief_title>
  <official_title>Activated Macrophages and Ozone Toxicity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to better understand the mechanisms of lung injury from ozone
      exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone.
      Subjects will be asked to produce sputum through coughing after each exposure. The samples
      will be analyzed for macrophage activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be asked to come to the Rutgers EOHSI clinical center (Piscataway, NJ) for 5
      study visits. A physical exam to determine eligibility will be done at the first study visit.
      If the subject is healthy and able to produce a sputum sample, he/she will then be scheduled
      for 2 3-hour exposure visits. One exposure will be to clean air and the other exposure will
      be to 0.2 ppm ozone. During the exposures, subjects will be requested to ride an exercise
      bicycle intermittently (approximately every 15 minutes). A follow-up visit for sputum
      collection will be scheduled either 24, 48, or 72 hours after each exposure visit. Blood,
      urine, and exhaled breath samples will also be collected at each visit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentrations of M1 and M2 macrophages in the sputum</measure>
    <time_frame>Within 3 days of exposure</time_frame>
    <description>The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Air Pollution</condition>
  <arm_group>
    <arm_group_label>Clean Air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will be exposed to clean air for 3 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ozone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be exposed to 0.2 ppm ozone for 3 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clean Air</intervention_name>
    <description>Subjects will have the clean air exposure first, followed by the ozone exposure</description>
    <arm_group_label>Clean Air</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ozone</intervention_name>
    <description>Subjects will have the ozone exposure first, followed by the clean air exposure</description>
    <arm_group_label>Ozone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women

        Exclusion Criteria:

          -  Cardiovascular disease

          -  Respiratory disease

          -  Diabetes

          -  Pregnancy

          -  HIV infection

          -  History of smoking within the last 5 years

          -  Daily use of antioxidant supplements (e.g., Vitamin C/E, selenium, beta-carotene,
             lycopene, lutein, zeaxanthin, or ginkgo biloba)

          -  Orthopedic or rheumatological conditions that would interfere with cycle use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard M. Kipen, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathy Black, PhD</last_name>
    <phone>848-445-6049</phone>
    <email>kgblack@eohsi.rutgers.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Hernandez</last_name>
    <phone>848-445-6120</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Environmental and Occupational Health Sciences Institute</name>
      <address>
        <city>Piscataway</city>
        <state>New Jersey</state>
        <zip>08854</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Black, PhD</last_name>
      <phone>848-445-6049</phone>
      <email>kgblack@eohsi.rutgers.edu</email>
    </contact>
    <contact_backup>
      <last_name>Marta Hernandez</last_name>
      <phone>848-445-6120</phone>
      <email>mh777@eohsi.rutgers.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2016</study_first_submitted>
  <study_first_submitted_qc>February 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2016</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Howard M. Kipen, MD, MPH</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Macrophage</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The individual data will be confidential.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

